Cardiovascular

Endeavor: Alternative Drug-Eluting Stent?

Jean Fajadet
Jean Fajadet

The ESC heard the latest on the Endeavor stent, which elutes the sirolimus analogue ABT-578. Jean Fajadet from Toulouse told Audio Medica about the findings from ENDEAVOR II study of around 1200 patients.

Click here for all the interviews from ESC 2005

Similar Interviews

  • ENDEAVOR or Cypher? Comparison of Drug Eluting Stents
  • The ABT578-eluting ENDEAVOR stent has been compared head-to-head with sirolimus-eluting Cypher. Duke University's David Kandzari told us more. [audio:http://www.audiomedica.com/podcasting/aha2005/David_Kandzari.mp3]Click here for

  • Audio Journal of Cardiovascular Medicine 11.3, October 2005
  • Reporting from: European Society of Cardiology Congress September 3-7, 2005, Stockholm In this edition: The RITA-3 trial - focussing on how to manage

  • Audio Journal of Cardiovascular Medicine 10.3, May 2004
  • Reporting from: European Society of Cardiology Congress, Munich, August 28-1 September, 2004 In this edition: The RITA-3 trial - focussing on how to

    Post a comment

    Subscribe to Audio Medica Podcast